Showing results (711-720 of 1,120) with videos related to

Sort By:
Pageof 112
JACC. Clinical Electrophysiology|September 19, 2024
Atrial Fibrillation Burden on a 14-Day ECG Monitor: Findings From the GUARD-AF Trial Screening ArmDaniel E Singer, Steven J Atlas, Alan S Go, et al.
Journal of the American College of Cardiology|September 4, 2024
Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke PreventionRenato D Lopes, Steven J Atlas, Alan S Go, et al.
Journal of the American Heart Association|December 3, 2015
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialMeena P Rao, Sigrun Halvorsen, Daniel Wojdyla, et al.
Journal of the American College of Cardiology|March 10, 2018
Digoxin and Mortality in Patients With Atrial FibrillationRenato D Lopes, Roberto Rordorf, Gaetano M De Ferrari, et al.
European Heart Journal. Acute Cardiovascular Care|August 4, 2016
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experienceSergio Leonardi, Renato D Lopes, Ph Gabriel Steg, et al.
American Heart Journal|March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trialsAndré Zimerman, Renato D Lopes, Amanda L Stebbins, et al.
Vascular Medicine (London, England)|July 12, 2018
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trialJeffrey S Berger, Beth L Abramson, Renato D Lopes, et al.
Journal of Ethnopharmacology|February 17, 2015
Hypotensive and vasorelaxant effects induced by the ethanolic extract of the Mimosa caesalpiniifolia Benth. (Mimosaceae) inflorescences in normotensive ratsM E P Santos, L H P Moura, M B Mendes, et al.
American Heart Journal|March 31, 2015
Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trialJan H Cornel, Renato D Lopes, Stefan James, et al.
American Heart Journal|September 24, 2017
Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF)Dragos Vinereanu, Hussein R Al-Khalidi, Meena P Rao, et al.
Pageof 112